![Courts Dismiss Two Whistleblower Lawsuits](https://www.g2intelligence.com/wp-content/uploads/2023/01/Feb23.LCA_.LabsInCourt-iStock-1800x1250-1-1080x675.jpg)
Courts Dismiss Two Whistleblower Lawsuits
In this month’s Labs in Court roundup, a medical device company and genetic testing company each win key victories.
In this month’s Labs in Court roundup, a medical device company and genetic testing company each win key victories.
Recent OIG report suggests some labs might have gamed Medicare coverage rules in 2020 by billing for unusually high numbers of such tests.
Some labs took advantage of COVID coverage rules to bill Medicare for medically unnecessary RPPs, allergy, and genetic tests.
Get an overview of trending areas of enforcement and steps labs and pathology practices can consider to protect their businesses.
Case is a recent example of the trend toward Medicare schemes involving telehealth, cancer genetic testing, and kickbacks.